Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives. 2023

Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.

Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterized by left ventricular (LV) hypertrophy, which cannot be entirely attributed to loading conditions such as valve or congenital heart disease or hypertension [...].

UI MeSH Term Description Entries

Related Publications

Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
February 2014, World journal of cardiology,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
May 2014, Current cardiology reports,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
April 2023, Current problems in cardiology,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
May 2015, European heart journal,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
January 2022, Journal of cardiac failure,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
November 2017, JBJS reviews,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
August 2021, International journal of molecular sciences,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
October 2010, Current opinion in pharmacology,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
January 2022, Tropical medicine and infectious disease,
Emanuele Monda, and Giuseppe Limongelli, and Francesco Pelliccia
August 2021, Molecular systems biology,
Copied contents to your clipboard!